Navigation Links
Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies

May 22, 2012 (Hackensack, NJ) John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will bring together leading cancer experts, for presentation and discussion of the latest developments and implications of cell therapy and interventional immunology in oncology, on Friday, June 7 from 7:00am to 1:30pm.

"I'm excited to bring together some of the nation's top immunology experts to review the latest developments and implications of cell therapies in oncology, both in solid and liquid tumors," said Andre Goy M.D., Cancer Center Director, and Chief of lymphoma, John Theurer Cancer Center and Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates. "This will provide an opportunity to see where the field is going and discuss some of the mechanisms and applications of T-cell manipulation as a promising tool against a number of cancers. The preliminary results seen with these modified T-cells will likely be revolutionary in the treatment of cancer".

The conference, titled "Cell Therapy and Interventional Immunology: Current Developments and Implications", is designed for hematologists, oncologists, physicians, and medical professionals. Given the enormous impact and growing interest in those therapies, the conference will also be offered to patients and caregivers through live online streaming. Speakers will cover the biology and manufacturing aspects of the chimeric antigenic receptor (CAR) modified T-cells as well as other manipulation of T-cells and the immune system, which for the first time, seem to be translating into impressive activity in the clinic.

The conference speakers and presentations include:

  • Catherine Bollard, MBChB, M.D., Professor of Pediatrics, Medicine, and Pathology & Immunology, Texas Children's Cancer Center, Baylor College of Medicine: Anti-EBV T-Cells and CAR T-Cells and Their Applications in Hematological Malignancies
  • Renier J. Brentjens, M.D., Ph.D., Leukemia Service, Memorial Sloan-Kettering Cancer Center: CAR Modified T-Cells for the Treatment of Cancer: Preclinical and Clinical Outcomes
  • Daniel H. Fowler M.D., Senior Investigator, Center for Cancer Research. National Cancer Institute: TH-2 Amplification and Other strategies to Reduce GVHD and Improve Outcome in Allogeneic Transplantations.
  • James N. Kochenderfer, M.D., Assistant Clinical Investigator, Center for cancer Research, National Cancer Institute: Autologous and Donor Derived Anti-CD19 CAR T-Cells Applications in non-Hodgkin Lymphoma and CLL
  • Cameron J. Turtle, M.D., Ph.D., Acting Instructor, University of Washington and Research Associate, Fred Hutchinson Cancer Research Center: Engineered Antigen Presenting Cells and T-Cells for Anti-Cancer Therapy

"Conferences such as this help physicians, medical professionals, as well as patients and caregivers to gain a better understanding of promising new treatment options, resulting in better clinical outcomes," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor, and Vice President of Cancer Services and President of Regional Cancer Care Associates, "John Theurer Cancer Center is committed to providing these conferences to improve patient care and education."


Contact: Amy Leahing
John Theurer Cancer Center

Related medicine news :

1. Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency
2. Mirena IUD Lawyers at Gilman Law LLP, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Anticipates Progress in Newly Established Mirena Federal Litigation
3. 30 Years of Orphan Drug Act, Combined with Science and Advocacy, Reflect Dramatic Progress in a Rare Lung Disease, Pulmonary Hypertension Association Says
4. Study evaluates effect of different supplements on reducing risk of progression to advanced AMD
5. Nina Brown Launches New Website for Spiritual Progressives
6. Despite superbug crisis, progress in antibiotic development alarmingly elusive
7. Progressive Dental Marketing Is Bringing Online Dental Marketing to Oregon for Dental Professionals Specializing in Laser Dentistry and Dental Implants
8. New findings on the brains immune cells during Alzheimers disease progression
9. Progressive Dental Marketing Is Bringing Online Dental Marketing to Oregon for Dental Professionals Specializing in Laser Dentistry and Dental Implants
10. Progressive Dental Marketing Is Bringing Online Dental Marketing to Washington for Dental Professionals Specializing in Laser Dentistry and Dental Implants
11. Progressive Dental Marketing Is Bringing Online Dental Marketing to Vancouver, B.C. for Dental Professionals Specializing in Laser Dentistry and Dental Implants
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology: